Industry Insights

  1. Advances In Seasonal Influenza Vaccine Development

    Learn 6 critical ways to keep track of the flu to optimize your seasonal flu vaccine development clinical trials.

  2. Genomic Assays For Clinical Development: Identifying The Right Approach

    Learn more about different genomic assays that can be used during clinical development and which ones are right for your study.

  3. The End To End Importance Of Selecting The Right Biomarker In Cancer Studies

    A critical component in the fight against cancer and optimizing treatment outcomes for patients.

  4. Zika Vaccine Research

    Discover the role of the central laboratory in Zika vaccine development and how you can proactively avoid challenges along the development continuum.

  5. New Approaches For Malaria Vaccine Development

    How advances in genetic engineering have brought new hope to conquering malaria.

  6. Genomic Based Solutions For Your Immuno-oncology Drug Development Needs

    Learn how genomics-based biomarker approaches can empower the success of your immuno-oncology clinical development programs by implementing a tailored biomarker strategy.

  7. The Benefits Of Blinding of Investigational Medicinal Products (IMPs)

    How blinding benefits both the patient and the investigator and drug encapsulation is an effective blinding method.

  8. Integrating Third-Party Lab Management To Streamline Clinical Development

    Real world experiences, pitfalls and best practices that can improve the efficiency of clinical development when centralizing and managing third party vendors.

  9. Clinical Trials Laboratories In The Immuno-Oncology Setting

    The development of immuno-oncology (I/O) medicines offer a new era of treatment options for physicians and patients. However, the level of sophistication required for biomarker selection, trial design, technology implementation, testing, and commercialization planning is unprecedented. Learn more about how clinical trial laboratories are utilizing multiple technologies and solutions to support immuno-oncology clinical development.

  10. Using Gene Signature Methodologies To Strengthen Immuno-Oncology Trials

    Cutting edge genomics technologies to power and enhance immuno-oncology (IO) trials where reporting transcriptional response pairs a person to therapy without multiple biopsies.